Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Prognostic biomarkers in osteoarthritis.

Attur M, Krasnokutsky-Samuels S, Samuels J, Abramson SB.

Curr Opin Rheumatol. 2013 Jan;25(1):136-44. doi: 10.1097/BOR.0b013e32835a9381. Review.

2.

Synovium and cartilage biomarkers in hemophilic arthropathy.

Rodriguez-Merchan EC.

Expert Rev Hematol. 2016;9(4):409-14. doi: 10.1586/17474086.2016.1141674. Epub 2016 Feb 3. Review.

PMID:
26761216
3.

Recent advances in biomarkers in osteoarthritis.

Patra D, Sandell LJ.

Curr Opin Rheumatol. 2011 Sep;23(5):465-70. doi: 10.1097/BOR.0b013e328349a32b. Review.

PMID:
21720244
4.

Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure.

Berry PA, Maciewicz RA, Wluka AE, Downey-Jones MD, Forbes A, Hellawell CJ, Cicuttini FM.

Ann Rheum Dis. 2010 Oct;69(10):1816-22. doi: 10.1136/ard.2009.124420. Epub 2010 Jun 15.

PMID:
20551154
5.

Value of biomarkers in osteoarthritis: current status and perspectives.

Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyère O, Chapurlat R, Collette J, Cooper C, Giacovelli G, Kanis JA, Karsdal MA, Kraus V, Lems WF, Meulenbelt I, Pelletier JP, Raynauld JP, Reiter-Niesert S, Rizzoli R, Sandell LJ, Van Spil WE, Reginster JY.

Ann Rheum Dis. 2013 Nov;72(11):1756-63. doi: 10.1136/annrheumdis-2013-203726. Epub 2013 Jul 29. Review. Erratum in: Ann Rheum Dis. 2017 May 25;:.

6.

Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.

Abadie E, Ethgen D, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Nuki G, Van De Putte L, Vanhaelst L, Reginster JY; Group for the Respect of Excellence and Ethics in Science.

Osteoarthritis Cartilage. 2004 Apr;12(4):263-8. Review.

7.

Biomarkers in osteoarthritis.

Abramson S, Krasnokutsky S.

Bull NYU Hosp Jt Dis. 2006;64(1-2):77-81. Review.

8.

Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers.

Dam EB, Loog M, Christiansen C, Byrjalsen I, Folkesson J, Nielsen M, Qazi AA, Pettersen PC, Garnero P, Karsdal MA.

Arthritis Res Ther. 2009;11(4):R115. doi: 10.1186/ar2774. Epub 2009 Jul 24.

9.

Biomarkers in osteoarthritis.

Garnero P, Delmas PD.

Curr Opin Rheumatol. 2003 Sep;15(5):641-6. Review.

PMID:
12960494
10.

Republished: Value of biomarkers in osteoarthritis: current status and perspectives.

Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyère O, Chapurlat R, Collette J, Cooper C, Giacovelli G, Kanis JA, Karsdal MA, Kraus V, Lems WF, Meulenbelt I, Pelletier JP, Raynauld JP, Reiter-Niesert S, Rizzoli R, Sandell LJ, Van Spil WE, Reginster JY.

Postgrad Med J. 2014 Mar;90(1061):171-8. doi: 10.1136/postgradmedj-2013-203726rep.

11.

Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time.

Lafeber FP, van Spil WE.

Osteoarthritis Cartilage. 2013 Oct;21(10):1452-64. doi: 10.1016/j.joca.2013.08.012. Epub 2013 Aug 14. Review.

12.

The role of synovitis in osteoarthritis pathogenesis.

Scanzello CR, Goldring SR.

Bone. 2012 Aug;51(2):249-57. doi: 10.1016/j.bone.2012.02.012. Epub 2012 Feb 22. Review.

13.

Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): study protocol for a randomized controlled trial.

Leung YY, Thumboo J, Wong BS, Haaland B, Chowbay B, Chakraborty B, Tan MH, Kraus VB.

Trials. 2015 Apr 30;16:200. doi: 10.1186/s13063-015-0726-x.

14.

Development and use of biochemical markers in osteoarthritis: current update.

Bay-Jensen AC, Thudium CS, Mobasheri A.

Curr Opin Rheumatol. 2018 Jan;30(1):121-128. doi: 10.1097/BOR.0000000000000467.

PMID:
29040157
15.

The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK.

Van Spil WE, Welsing PM, Bierma-Zeinstra SM, Bijlsma JW, Roorda LD, Cats HA, Lafeber FP.

Osteoarthritis Cartilage. 2015 Aug;23(8):1388-97. doi: 10.1016/j.joca.2015.03.023. Epub 2015 Mar 26.

16.

Use of imaging techniques to predict progression in osteoarthritis.

Ding C, Zhang Y, Hunter D.

Curr Opin Rheumatol. 2013 Jan;25(1):127-35. doi: 10.1097/BOR.0b013e32835a0fe1. Review.

PMID:
23080226
17.

Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis.

Ritter SY, Collins J, Krastins B, Sarracino D, Lopez M, Losina E, Aliprantis AO.

Arthritis Res Ther. 2014 Oct 7;16(5):456. doi: 10.1186/s13075-014-0456-6.

18.

Osteoarthritis year 2012 in review: biomarkers.

Mobasheri A.

Osteoarthritis Cartilage. 2012 Dec;20(12):1451-64. doi: 10.1016/j.joca.2012.07.009. Epub 2012 Jul 25. Review.

19.

Association between ultrasonographic findings and bone/cartilage biomarkers in patients with early-stage knee osteoarthritis.

Kumm J, Tamm A, Lintrop M, Tamm A.

Calcif Tissue Int. 2009 Dec;85(6):514-22. doi: 10.1007/s00223-009-9302-2. Epub 2009 Oct 28.

PMID:
19862466
20.

Biomarkers for osteoarthritis: Can they be used for risk assessment? A systematic review.

Hosnijeh FS, Runhaar J, van Meurs JB, Bierma-Zeinstra SM.

Maturitas. 2015 Sep;82(1):36-49. doi: 10.1016/j.maturitas.2015.04.004. Epub 2015 Apr 14. Review.

PMID:
25963100

Supplemental Content

Support Center